Editorial Commentary
Hybrid minimally invasive esophagectomy for esophageal cancer: less is more
Abstract
In a recently published multi-center randomized controlled trial (New England Journal of Medicine 2019;380:152-162) Christophe Mariette and colleagues compared open transthoracic esophagectomy to hybrid esophagectomy (open thoracic phase, laparoscopic abdominal phase) for patients with resectable cancer of the middle or lower third of the esophagus (MIRO trial) (1).
